Patents by Inventor Peter John Bugelski

Peter John Bugelski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020142354
    Abstract: A method for analyzing the protein or peptide content of a mixture comprising exposing a spatial array of protein recognition units to the protein or peptide containing mixture, and detecting the binding of proteins or peptides to the protein recognition units.
    Type: Application
    Filed: January 24, 2002
    Publication date: October 3, 2002
    Inventors: Sophie Elizabeth Victoria Wildsmith, Rhiannon Yallop, Peter John Bugelski, David Gwyn Morgan
  • Publication number: 20010056066
    Abstract: An improved method of treating immune cell mediated systemic diseases, particularly T and B cell mediated diseases, is provided by increasing the systemic exposure, or bioavailibility, of a therapeutic protein. Such therapeutic protein is selected from the group consisting of a monoclonal antibody, a soluble receptor and a soluble ligand which binds to an antigen expressed on the surface of an immunce cell.
    Type: Application
    Filed: July 13, 2001
    Publication date: December 27, 2001
    Applicant: SmithKline Beecham Corporation
    Inventors: Peter John Bugelski, Charles Baldwin Davis, Brian Richard MacDonald
  • Patent number: 5786376
    Abstract: Invented is a method of treating opportunistic infections in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a substituted azaspirane.
    Type: Grant
    Filed: January 21, 1997
    Date of Patent: July 28, 1998
    Assignee: SmithKline Beecham Corporation
    Inventors: Alison Mary Badger, Peter John Bugelski, Danuta J. Herzyk